http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006026977-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10d2d8666cf42fa5fb38e985ff48dce2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_703722e65e0ca90a53065a65cfc2a597
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97706fa1e18250ec676f4c358f15ac6f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-23
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
filingDate 2005-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00cb2c316d346e7e264df5a0cc1d18e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11fee357057dd3ddb1ee4778bcdf7c89
publicationDate 2006-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006026977-A2
titleOfInvention Polypeptides and method for specifically binding prions
abstract The invention relates to polypeptides that have at least one sequence motif and that specifically bind to the pathological isoform of a prion protein. The invention also relates to the uses thereof and to a method for specifically binding the pathological isoform of a prion protein (PrP<sup
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1705182-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8372406-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7439041-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1705182-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7834144-B2
priorityDate 2004-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413143
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408122
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124886
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129773695
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67149
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4911
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18185437
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4784
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127708637
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400160
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414233
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880

Total number of triples: 42.